drugset / Trial / NCT04707950
Tranexamic Acid for the Prevention of Postpartum Haemorrhage
RandomizedParallel-groupOpen-labelPrevention
Summary
Use of tranexamic acid (TXA) for the prevention of postpartum haemorrhage (PPH) after cesarean section in high-risk patients ( a randomized control trial ).
Timeline
- Start
- 2020-01-01
- Primary completion
- 2021-02-25
- Completion
- 2021-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tranexamic Acid | Small molecule | 1 g | Intravenous |
| Comparator | Oxytocin | Peptide | — | — |
Indications
No indication recorded.